$246.04
2.170.89%
At close: Aug 7, 5:00 PM EST
$245.89
-0.15-0.06%
After Hours: Aug 7, 6:53 PM EST
AbbVie Inc
ABBVNYSE
AbbVie Earnings & Forecasts
AbbVie (ABBV) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
AbbVie Guidance
AbbVie (ABBV) last issued guidance on July 31, 2026 for fiscal year 2026. The company guided earnings per share in the range of $13.87 - $14.07, compared to a consensus EPS estimate of $14.25. AbbVie also guided revenue in the range of $67.6B - $67.6B for the period.
Compared to prior guidance, AbbVie maintained its EPS outlook from a previous range of $13.91 - $14.11. On the revenue side, the company maintained its revenue forecast from a prior range of $67.3B - $67.3B.
AbbVie has issued 65 guidance updates between October 5, 2022 and July 31, 2026. During this period, the company raised its outlook 11 times and lowered it 35 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $3.77 | $2.66 | $2.66 | $1.78 |
| Actual | $3.65 | $2.65 | $2.71 | $1.86 |
| Surprise | -3.18% | -0.38% | +1.88% | +4.49% |
| Revenue | ||||
| Estimate | $16.76B | $14.73B | $16.39B | $15.59B |
| Actual | $16.99B | $15.00B | $16.62B | $15.78B |
| Surprise | +1.37% | +1.84% | +1.37% | +1.21% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $3.85 | $3.89 | $3.38 | $4.11 |
| Revenue | ||||
| Consensus | $17.32B | $18.30B | — | — |
